2011: Identification of Novel Drugs to Halt the Metastasis of Tumors That Cause Cushing's Syndrome
Grant Status: Closed
AbstractTumors of the adrenal gland that lead to Cushing's syndrome are characterized by excessive cortisol secretion which in turn causes these tumors to be aggressive and rapidly metastasize. Recently, a critical role of steroidogenic factor (SF-1) in adrenal tumor formation has been demonstrated. Elevated SF-1 levels trigger tumor formation in mice and are associated with poor prognosis in humans and dogs. Blocking SF-1 with medical compounds (SF-1 inverse agonists) may suppress both tumor growth and cortisol production, thus enhancing the ability of veterinary surgeons to successfully remove adrenocortical tumors and prevent metastasis. In this study, Dr. Galac will obtain adrenal cancer cells from dogs after adrenal surgery and culture these tumors with SF-1 inverse agonists. The effect of these SF-1 agonists on cortisol production and cell growth will be evaluated, and if drugs are found to suppress cortisol production, Dr. Galac predicts they can enter the drug pipeline for the treatment of canine adrenal cancer. Due to the similarities with adrenal cancer in humans, the results of this study could be applied to human medicine.
Galac, S., Kool, M. M., van den Berg, M. F., Mol, J. A., & Kooistra, H. S. (2014). Expression of steroidogenic factor 1 in canine cortisol-secreting adrenocortical tumors and normal adrenals. Domest Anim Endocrinol, 49, 1-5. doi:10.1016/j.domaniend.2014.04.002
Sanders, K., Mol, J. A., Slob, A., Kooistra, H. S., & Galac, S. (2018). Steroidogenic factor-1 inverse agonists as a treatment option for canine hypercortisolism: in vitro study. Domest Anim Endocrinol, 63, 23-30. doi:10.1016/j.domaniend.2017.11.001
Help Future Generations of Dogs
Participate in canine health research by providing samples or by enrolling in a clinical trial. Samples are needed from healthy dogs and dogs affected by specific diseases.